Showing results (1441-1450 of 3,791) with videos related to
Sort By:
Pageof 380
Oncoimmunology|January 10, 2014
Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunologyZaheed Husain, Pankaj Seth, Vikas P SukhatmeOncoimmunology|April 2, 2021
Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situFei-Fei Xu, Sai-Fang Zheng, Cheng Xu, et al.Oncoimmunology|April 2, 2021
Combination of EP4 antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cellsYun Wang, Long Cui, Peter Georgiev, et al.Oncoimmunology|April 2, 2021
Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemiaAroa Baragaño Raneros, Ramon M Rodriguez, Aida Bernardo Flórez, et al.Oncoimmunology|April 2, 2021
Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugsCesar Oyarce, Ana Vizcaino-Castro, Shipeng Chen, et al.Oncoimmunology|April 2, 2021
Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota compositionLucia Lione, Erika Salvatori, Adriana Petrazzuolo, et al.Oncoimmunology|April 2, 2021
Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanomaMarius Ilié, Elisabeth Lantéri, Emmanuel Chamorey, et al.Oncoimmunology|April 23, 2021
Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538Oliver Klein, Clare Senko, Matteo S Carlino, et al.Oncoimmunology|April 10, 2023
Tissue-resident memory T cells in immune-related adverse events: friend or foe?Robin Reschke, Thomas F GajewskiOncoimmunology|April 7, 2023
Beyond checkpoint inhibition: PD-1 cis-targeting of an IL-2Rβγ-biased interleukin-2 variant as a novel approach to build on checkpoint inhibitionLaura Codarri Deak, Masao Hashimoto, Pablo Umaña, et al.Pageof 380